UNITED STATES SECURITIES AND EXCHANGE COMMISSION
                             WASHINGTON, D.C. 20549

                                 SCHEDULE 14F-1

                              INFORMATION STATEMENT
                         PURSUANT TO SECTION 14F OF THE
                         SECURITIES EXCHANGE ACT OF 1934
                            AND RULE 14F-1 THEREUNDER


                           Lifeline Therapeutics, Inc.
                 ----------------------------------------------
        (Exact name of registrant as specified in its corporate charter)


                           Yaak River Resources, Inc.
                       ---------------------------------
                                  (Former Name)

                                    000-30489
                            -----------------------
                              (Commission File No.)


          Colorado                                84-1097796
          ---------                               ----------
   (State of Incorporation)            (IRS Employer Identification No.)


       6400 South Fiddler's Green Circle, Suite 1750, Englewood, CO 80111
         --------------------------------------------------------------
                    (Address of principal executive offices)


                                  (720)488-1711
                         ------------------------------
                         (Registrant's telephone number)








                           LIFELINE THERAPEUTICS, INC.

        NOTICE TO SHAREHOLDERS PURSUANT TO SECTION 14F OF THE SECURITIES
                 EXCHANGE ACT OF 1934 AND RULE 14F-1 THEREUNDER

             ------------------------------------------------------
        NO VOTE OR OTHER ACTION OF THE COMPANY'S STOCKHOLDERS IS REQUIRED
       IN CONNECTION WITH THIS INFORMATION STATEMENT. NO PROXIES ARE BEING
        SOLICITED AND YOU ARE NOT REQUESTED TO SEND THE COMPANY A PROXY.


GENERAL

This  Information  Statement is being mailed on or about October 21, 2004 to the
holders of record as of October 6, 2004,  of common stock (the "common  stock"),
of Lifeline  Therapeutics,  Inc., a Colorado  corporation formerly known as Yaak
River  Resources,  Inc.  (the  "Company").  You are receiving  this  Information
Statement in connection  with the Company's  appointment of new directors to the
Board of Directors of the Company (the "Designee") and its anticipated change of
control.

On September 21, 2004, Yaak River Resources entered into a Plan and Agreement of
Reorganization with Lifeline  Nutraceuticals,  Inc. When completed, the Plan and
Agreement of Reorganization will result in:

o    the shareholders of Lifeline  Nutraceuticals  acquiring at least 80% of the
     Company's common stock if all Lifeline  Nutraceutical  shareholders  tender
     their shares (which cannot be assured);

o    the Company changing its name to Lifeline Therapeutics, Inc. (a name change
     was approved by the Company's  shareholders in June 2004) The name has been
     changed to Lifeline Therapeutics, Inc. as of October 5, 2004;

o    the Company  completing its 1-for-68  reverse stock split (also as approved
     by the  Company's  shareholders  in June 2004).  This was  completed  as of
     October 5, 2004;

o    the  Company  having  a new  trading  symbol  on  the  OTC  Bulletin  Board
     (completed as of October 5, 2004);

o    the Company assuming Lifeline Nutraceutical's  outstanding convertible debt
     (in a  total  amount  of  $240,000  plus  accrued  interest  which  will be
     convertible into 480,000 shares of the Company's common stock);

o    the  Company  assuming  Lifeline   Nutraceuticals'  bridge  loan  financing
     ($400,000  plus  accrued  interest  outstanding  as of October 1, 2004) and
     honoring the terms thereof in connection with any future private placement;

o    the Company assuming Lifeline  Nutraceuticals  obligation to issue warrants
     to  purchase  its common  stock to holders of notes  representing  Lifeline
     Nutraceuticals' bridge loan financing.  (Bridge loan holders will receive a
     number of warrants  equivalent  to their loan  amount  divided by the share
     price in a future  financing  if one  should  occur.  The  total  number of

                                       2


     warrants  that may be issued,  and the price at which the  warrants  may be
     exercised  cannot not be estimated due to adjustment  clauses in the Bridge
     Financing Agreements.)

o    the Company's board of directors and management changing.

We expect  that the  closing  of this  transaction  will take  place on or after
October 12, 2004 and that  following  the closing the Company  will own at least
80% of the outstanding capital stock of Lifeline Nutraceuticals, Inc.

The existing  board of directors of the Company  approved the Plan and Agreement
of Reorganization with Lifeline Nutraceuticals,  and further approved employment
agreements with Messrs.  Driscoll,  Myhill,  and Streets.  The existing board of
directors also approved amended and restated  articles of incorporation  for the
Company  which will be presented to the  shareholders  for approval at a meeting
expected to be held in January 2005.  Finally,  the existing  board of directors
also  approved a contract  with Donald  Smith,  a  significant  shareholder  and
creditor of the Company,  to exchange certain real property owned by the Company
in Victor, Colorado, for cancellation of the Company's indebtedness to him. This
contract will also be presented to the  shareholders of the Company for approval
at the next shareholders' meeting.

At the completion of the  reorganization,  Blaize N. Kaduru and Robert Pike will
submit their  resignations  from the Board of  Directors  of the Company,  which
resignations  shall be effective ten days after this Notice to  Shareholders  is
mailed or at the  completion  of the  transaction  contemplated  in the Plan and
Agreement of Reorganization,  whichever is later. At the closing, Mr. Kaduru and
Mr. Pike will expand the  Company's  board of directors to four persons and they
will appoint  William  Driscoll  and Paul  Myhill.  Effective 10 days after this
Notice to Shareholders is mailed or (if later) the completion of the transaction
contemplated in the Plan and Agreement of Reorganization,  Messrs.  Driscoll and
Myhill will appoint Daniel W. Streets and Christopher J. Micklatcher to fill the
two vacancies created by Messrs. Kaduru's and Pike's resignation.

Assuming the closing of the Plan and Agreement of Reorganization at closing, the
board of directors (which then will include Messrs.  Kaduru,  Pike, Driscoll and
Myhill) is expected to appoint the following officers:

- William  Driscoll will be appointed  President and Chief  Executive  Officer 
- Paul Myhill will be  appointed  Vice  President;  and 
- Daniel  Streets  will be appointed Treasurer and Secretary.

At or immediately before the board meeting, Blaize N. Kaduru will resign as CEO,
President, Secretary and Treasurer. Robert Pike will resign as Vice President.


CONSUMMATION OF A TRANSACTION HAS RESULTED IN A CHANGE OF CONTROL.
------------------------------------------------------------------

On  September  21,  2004,  Yaak River  Resources,  Inc.  entered into a Plan and
Agreement with Lifeline  Nutraceuticals  Corp.  whereby Lifeline  Nutraceuticals
Corp.  agreed to propose to its  shareholders  an  exchange  of the  outstanding
shares of  Lifeline  stock for 80% of the issued and  outstanding  shares of the
Company on a post reverse split basis.

                                       3


In addition,  as described above, the Company will assume certain obligations of
Lifeline  Nutraceuticals  with  respect  to its  outstanding  convertible  debt,
bridge-loan financing, and obligation to issue common stock purchase warrants.

No action is required by the shareholders of the Company in connection with the
appointment  of the new  persons to the  Board.  However,  Section  14(f) of the
Securities  Exchange Act of 1934, as amended (the "Exchange Act"),  requires the
mailing to the Company's  shareholders this Information  Statement not less than
ten days prior to the change in a majority of the Company's  directors otherwise
than at a meeting of the Company's shareholders.


VOTING SECURITIES AND PRINCIPAL HOLDERS THEREOF

VOTING SECURITIES OF THE COMPANY:

On October 6, 2004 (as adjusted for the one-for-68 reverse stock split effective
as of October 5, 2004), there were approximately 989,836 shares of the Company's
common stock issued and  outstanding.  Following  the  completion of the plan of
reorganization  with  Lifeline  Nutraceuticals,   there  will  be  approximately
16,374,946  shares of the  Company's  common  stock  outstanding  assuming  that
holders  of  only  80%  of  the  outstanding  Lifeline   Nutraceuticals   shares
participate  in the share  exchange).  Each share of common  stock  entitles the
holder  thereof to one vote on each matter that may come before a meeting of the
shareholders.

SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT:

The sole class of equity securities of the Company issued and outstanding is the
common stock.

The following  table sets forth,  as of October 6, 2004 on a post-reverse  split
basis (and as adjusted  for the issuance of shares to  shareholders  of Lifeline
Nutraceuticals,  Inc.  holding 80% of the  outstanding  Lifeline  Nutraceuticals
common stock), certain information with respect to the common stock beneficially
owned by: (i) each Director,  nominee and executive officer of the Company; (ii)
each person who owns  beneficially  more than 5% of the common stock;  and (iii)
all  Directors,  nominees  and  executive  officers  as a group.  If the Company
acquires more than 80% of the  outstanding  shares,  the ownership  interests of
each of the named persons will be diluted.


                                       4



  (i) each Director, nominee and executive officer of the Company:

                                                      Post           Post
                            Pre-Transaction           Transaction    Transaction
Name and Address of         Amount and nature of      Number of      % of Class
Beneficial Owner            Beneficial Ownership      Shares
-------------------------------------------------------------------------------
Blaize N. Kaduru (1)                0                      0               0%
423 Baybridge Drive
Sugarland, TX  77478
-------------------------------------------------------------------------------
Robert Pike (1)                10,000                 10,000               .06%
423 Baybridge Drive
Sugarland, TX  77478
--------------------------------------------------------------------------------
William Driscoll (2)                0              5,623,800             34.34%
6400 South Fiddler's
Green Circle, Suite 1750
Englewood, CO 80111
-------------------------------------------------------------------------------
Paul Myhill (2)                     0              4,699,890             28.70%
6400 South Fiddler's
Green Circle, Suite 1750
Englewood, CO 80111
-------------------------------------------------------------------------------
Daniel W. Streets (2)(3)            0              2,008,500             12.27%
6400 South Fiddler's
Green Circle, Suite 1750
Englewood, CO 80111
-------------------------------------------------------------------------------
Christopher J. Micklatcher (2)      0                562,380              3.43%
6400 South Fiddler's
Green Circle, Suite 1750
Englewood, CO 80111
-------------------------------------------------------------------------------
(1) Resigning Director
(2) New Director
(3) Does not includes  shares that may be acquired by Mr.  Streets'  wife's Roth
IRA if she should chose to convert the $82,000 she has invested  through  Bridge
Loan financing into the Private  Placement or exercise the warrants  attached to
the Private  Placement  or the warrants  attached to the Bridge Loan  financing.
Conversion  price and the  exercise  price of the  attached  warrants  cannot be
determined until the Private Placement share price is determined.

All of the above  disclaim  any  beneficial  ownership  in shares of the Company
owned by other family members.

                                       5




  (ii) each person who owns beneficially more than 5% of the common stock (based
on the  Company  acquiring  80% of the  outstanding  common  stock  of  Lifeline
Nutraceuticals as described above):

                                                        Post         Post
                                Pre-Transaction         Transaction  Transaction
Name and Address of             Amount and nature of    Number of    % of Class
Beneficial Owner                Beneficial Ownership    Shares
                               (post-reverse split)
-------------------------------------------------------------------------------
Eric Sunsvold                        98,450              98,450            .60%
423 Baybridge Drive
Sugarland, TX  77478
-------------------------------------------------------------------------------
Donald J. Smith                     405,617 (1)         456,618           2.80%
2501 E. Third Street
Casper, WY  82609
-------------------------------------------------------------------------------
Darrell Benjamin                     63,603              63,603            .39%
6658 S. Starlight Rd.
Morrison, CO 80465
-------------------------------------------------------------------------------
William Driscoll (2)                      0           5,623,800          34.34%
6400 South Fiddler's
Green Circle, Suite 1750
Englewood, CO 80111
-------------------------------------------------------------------------------
Paul Myhill (2)                           0           4,699,890          28.70%
6400 South Fiddler's
Green Circle, Suite 1750
Englewood, CO 80111
-------------------------------------------------------------------------------
Daniel Streets(2)                         0           2,008,500          12.27%
6400 South Fiddler's
Green Circle, Suite 1750
Englewood, CO 80111
-------------------------------------------------------------------------------
Joseph McCord                             0           1,928,160          11.78%
6400 South Fiddler's
Green Circle, Suite 1750
Englewood, CO 80111
-------------------------------------------------------------------------------

(1) The figure  shown  includes  147 shares  held in the name of Suvo Corp.  Mr.
Smith is the beneficial owner of Suvo Corp.
(2) New Director


                                       6




  (iii) all Directors, nominees and executive officers as a group:

                                            Number of         Percentage
                                            Shares            of Class
-------------------------------------------------------------------------------
All Current Officers and
Directors as a Group*                         10,000            .06%
-------------------------------------------------------------------------------
Officers & Directors as a
Group, counting new appointees
and excluding resigning directors*        12,894,570          78.75%
-------------------------------------------------------------------------------
Total Shares Issued and
Outstanding Post Transaction*             16,374,945         100.00%
-------------------------------------------------------------------------------

*based on the Company acquiring 80% of the outstanding  common stock of Lifeline
Nutraceuticals as described above

Unless otherwise indicated,  the persons named in the table have sole voting and
investment   power  with  respect  to  all  shares  of  common  stock  shown  as
beneficially owned by them.

DIRECTORS AND EXECUTIVE OFFICERS
--------------------------------

The following sets forth the names and ages of the current  Directors,  nominees
for  directors and executive  officers of the Company,  the principal  positions
with the  Company  held by such  persons  and the  date  such  persons  became a
Director or executive officer. The Directors serve one year terms or until their
successors are elected.  The Company has not had standing  audit,  nominating or
compensation  committees  of the Board of  Directors  or  committees  performing
similar  functions.  All such  applicable  functions  have  been by the Board of
Directors as a whole.  During the fiscal year ended December 31, 2003, the Board
of Directors held no formal meeting. There are no family relationships among any
of the Directors, nominees or executive officers.

BLAIZE N. KADURU.  Mr. Kaduru is an Adjunct  Professor,  teaching  economics and
business related college courses at Wharton Junior College in Sugarland,  Texas,
since January 2003.  Previously,  he was  Executive  Vice  President of Business
Development for Wireless Communications Technology,  Inc., a spin-off of Prodigy
Communications Inc. in Houston,  Texas. Mr. Kaduru will resign as CEO, President
and  Secretary/Treasurer of Yaak River Resources,  Inc. at the completion of the
transactions  contemplated in the Plan and Agreement of Reorganization (expected
to occur on or after October 12, 2004) and will resign as Director  effective 10
days after the Notice to Shareholders is mailed,  in compliance with Section 14f
of the  Securities  Exchange Act of 1934, or the  completion of the  transaction
contemplated in the Plan and Agreement of Reorganization, whichever is later.

ROBERT  PIKE.  Mr.  Pike has been Vice  President  and a Director of the Company
since  December 21, 1999. Mr. Pike is a retired  banker.  For more than the past
five years, he has been an investor. Also for more than the past five years, Mr.
Pike has been  President  and sole owner of Bob Pike  Associates,  Inc.,  a real
estate consulting and inspection firm, based in Englewood, Colorado, that serves
financial  institutions.  Mr. Pike will resign as Vice  President  of Yaak River

                                       7


Resources,  Inc. at the completion of the transactions  contemplated in the Plan
and Agreement of Reorganization  (expected to occur on or after October 12, 2004
and will resign as Director  effective 10 days after the Notice to  Shareholders
is mailed,  in  compliance  with Section 14f of the  Securities  Exchange Act of
1934,  or the  completion  of the  transaction  contemplated  in  the  Plan  and
Agreement of Reorganization, whichever is later.

WILLIAM J. DRISCOLL,  will become PRESIDENT AND a DIRECTOR. Mr. William Driscoll
has a background in management and marketing.  At 25 he was the plant manager or
United  Solder Wrap and became the  President  of Union  Petroleum  in 1987.  He
entered the  financial  industry in 1988 and within  three years was promoted to
branch  manager,  regional  manager and finally  national sales manager of L. F.
Thomson.

Mr.  Driscoll has worked at such  nationally-respected  firms as Dean Witter and
Merrill Lynch. Mr. Driscoll has held speaking engagements at several Fortune 500
companies  including  American  Airlines,  Alcatel,  E Systems,  3M and Rockwell
International.  From 1998 until 2003 he was  President  of Destiny  Advisors,  a
"Strategic  Management"  consulting  firm who  assisted  companies  with writing
business  plans and news  releases,  in addition to recruiting key personnel for
client  companies,  including CEO's,  CFO's,  directors and qualified  marketing
persons.

PAUL R. MYHILL, will become VICE PRESIDENT and a DIRECTOR.  Paul Myhill received
his MBA from the  University  of Texas at Austin  in 1990,  in  Marketing  Brand
Management).  As a self-employed  entrepreneur and consultant since 1989, he has
been involved in planning, funding, and launching business ventures. During that
period,  he  has  led  six  different   business  ventures  which  all  required
significant  capital  investment  and  bottom-line   management.   Mr.  Myhill's
specialization  is in the area of  business  and  product  marketing.  He is the
former owner of an advertising  and media  placement  agency,  USAboards,  Inc.,
co-owner of a financial  public  relations  firm,  Fair Market  Value,  LLC, and
founder and  President of NABO,  Inc., a specialty  distribution  business  with
multiple  warehouse  operations.  Mr.  Myhill has  developed  and overseen  many
marketing  and  product  distribution  plans.  Mr.  Myhill  filed  for  personal
bankruptcy  in Texas in November  1997,  and received a discharge in April 1998.
The personal  bankruptcy resulted from the failure of a business he was managing
where personal and business funds and expenses were co-mingled.

Mr. Myhill has served on numerous  corporate boards  (for-profit and non-profit)
and presently sits on the board of directors for Brookstone Christian Academy of
Colorado as an organizational and promotional advisor.  From December of 1998 to
April of 2002 Mr. Myhill was Director of Missions at Bent Tree Bible  Fellowship
and then from April of 2002 to November  of 2002 he became  Director of Projects
at Chinese Children's  Charities.  In November of 2002 he was Pastor of Missions
and Membership at Faith Baptist Church until September of 2003.

CHRISTOPHER J. MICKLATCHER,  will become a DIRECTOR.  Mr. Micklatcher has been a
certified  public  accountant  and attorney  practicing in the state of Michigan
since 1990.  Mr.  Micklatcher  graduated from the University of Michigan in 1980
with a BBA in Finance and Accounting,  and (in 1984) from Wayne State Law School
with  a J.D.  specializing  in Tax  Law.  He is  currently  licensed  as  both a
certified  Public  Accountant and Attorney.  Mr.  Micklatcher has specialized in
implementing  accounting,  compliance  and tax systems for clients  ranging from
Fortune 100  companies  to small start up  operations.  He is the  President  of
Alternative Tax Solutions, a full service legal, accounting, tax preparation and
consulting practice  specializing in assisting small businesses and individuals.
Mr.  Micklatcher  is a member of the  American  Institute  of  Certified  Public

                                       8


Accountants  as  well as the  Michigan  Bar  Association.  Mr.  Micklatcher  was
Director of Triad Innovations, Inc. (2001-2002) and President in 2002.

DANIEL W. STREETS, will become SECRETARY,  TREASURER and a DIRECTOR. Mr. Streets
was a Manager of KPMG Peat Marwick  (from June 1975 to June 1983) and has served
as the CFO of six  corporations,  including  high-volume  companies  with annual
revenues  in excess of  $400,000,000.  A few of these  companies  include  Vista
Travel  Ventures  from May of 1999 to  February  of 2001 and Sopris  Development
Group from May 2001 to December of 2003.


FAMILY RELATIONSHIPS.               None.
--------------------

STANDING AUDIT COMMITTEE.           None.
------------------------

NOMINATION COMMITTEE.               None.
--------------------

COMPENSATION COMMITTEE.             None.
----------------------

EXECUTIVE COMPENSATION

  (1) Cash Compensation

Directors who are also officers of the Company receive no cash  compensation for
services  as  Directors.  The  Company  has  made  no cash  compensation  to its
executives in the past but will pay cash  compensation  to its executives in the
future  pursuant to employment  agreements to be entered with new  management as
approved by the Company's existing board of directors. The employment agreements
will  provide for a term of two years,  will be  terminable  for cause or upon a
change of control, and will provide for base salaries as follows:

         William Driscoll -- $180,000 per year
         Paul Myhill -- $120,000 per year
         Daniel W. Streets -- $120,000 per year

Following the completion of the  reorganization,  the Company  expects to obtain
normal employee benefits (such as health insurance and life insurance),  and may
provide its executives and other employees additional benefits. In addition, The
Company  will  likely  hire other  employees  to assist in the new  business  of
Lifeline  Therapeutics.  The  Company  has not  determined  whether to hire such
employees at the Company or in its future subsidiary, Lifeline Nutraceuticals.

The Company has made no Long Term Compensation payout.

  (2) Stock Option Plan

The Company's directors prior to the acquisition had not approved a stock option
plan.

LEGAL PROCEEDINGS:

The  Company  is not  aware of any  legal  proceedings  in which  any  Director,
nominee,   officer  or  affiliate  of  the  Company,  any  owner  of  record  or
beneficially of more than five percent of any class of voting  securities of the
Company, or any associate of any such Director,  nominee, officer,  affiliate of
the Company,  or security holder is a party adverse to the Company or any of its

                                       9


subsidiaries  or has a material  interest  adverse to the  Company or any of its
subsidiaries.

COMPLIANCE WITH SECTION 16(A) OF THE SECURITIES EXCHANGE ACT:

Section  16(a) of the  Securities  Exchange Act of 1934  requires the  Company's
Directors and executive  officers and persons who own more than ten percent of a
registered class of the Company's equity  securities to file with the Securities
and Exchange  Commission  ("SEC")  initial  reports of ownership  and reports of
changes in  ownership of the common  stock and other  equity  securities  of the
Company.  Officers,  Directors  and greater  than ten percent  stockholders  are
required by SEC  regulations  to furnish the Company  with copies of all Section
16(a) forms they file.  The  information  in this section is based solely upon a
review of the Forms 3, 4 and 5 received by the Company.

The following persons who were directors, officers, or beneficial owners of more
than ten percent of the common stock of the Company, failed to file, on a timely
basis,  reports required by Section 16(a) of the Securities Exchange Act of 1934
since  the  company  filed  it  Registration  Statement  of Form  10SB  with the
Securities Exchange Commission.

                                  Form 3            Form 4            Form 5
                                  ------------------------------------------

1. Blaize N. Kaduru                 1 in 2002      1 in 2003            2003
                                                                        2004

2. Robert Pike                      1 in 2002      1 in 2003            2003
                                                                        2004


All of the above have  indicated  they will file the  appropriate  Forms  within
thirty (30) days.


OTHER INFORMATION:

The Company files periodic  reports,  proxy  statements and other documents with
the Securities and Exchange  Commission.  You may obtain a copy of these reports
by accessing the Securities and Exchange Commission's website which can be found
at http://www.sec.gov.


Dated:  October 14, 2004

                           By Order of the Board of Directors
                           Lifeline Therapeutics, Inc.


                       By:/s/Blaize Kaduru                                 
                          ------------------------------------
                            Blaize Kaduru, President


                                       10